You make sense, but just about any literature made public will not be as informative as the PDR. I have Web MD and the Mayo clinic sites on my favorites but even they do not go into the depth that the PDR will. If the subject was OPT IN and not OPT OUT I would have no problem with it...Each parent can decide if they want to put their daughters at risk after having FULL information. :O)
Do you know where the PDR information comes from? It is provided by the manufacturer.
With regard to new medications it can only reference the reactions of a few hundred, perhaps the very low thousands of people it was tested on.
While I still remain a supporter of the PDR being included in the evaluation process, I still don’t think it’s the be-all end-all of decision making when it comes to new medications.
I have forgotten the name of the medication now, but years ago a medication was brought over from Europe by a very large pharmaceutical manufacturer in the United States. In under a year, that medication garnered the company $120 million dollars in profits. And then it was taken off the market.
The pharmaceutical manufacturer was found to have left out information in it’s presentation during the FDA approval process. It was not presented in the PDR either.
There was a known problem that resulted in deaths and real harm to people taking the medication.
I’m just saying that the information in the PDR is not always the full gospel on medications, and people need to do their own due diligence and not rely on it as the final arbiter of what is okay to take or not.